CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wedbush Adjusts Price Target on Vera Therapeutics to $34 From $43, Maintains Neutral Rating

Negative
AI Analysis

Summary

Wedbush reduced its price target on Vera Therapeutics from $43 to $34 while maintaining a Neutral rating, reflecting a downward valuation adjustment.

Importance:2/10
Sentiment:
-0.60
price_target_reductionanalyst_ratingvaluation
Related Companies

Read the original article

Published by yahoo_finance on August 11, 2026 11:17 AM

Read Original